As feedback, benign T cells in cutaneous T-cell lymphoma express interleukin 22 (Il-22), which may foster the expression of chemokine ligand 20 (CCL20) expression via STAT3 activation [59]. This evidence concerns the gene IL22 and primary cutaneous T-cell non-Hodgkin lymphoma.